Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers
Clinical trial NCT03522012 · COMPLETED
Trial details
- NCT number
- NCT03522012
- Sponsor
- Mycenax Biotech Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-17
- Primary completion
- 2018-09-26
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.